Hijnen D
No ORCID on file
· 1 paper in corpus
BackgroundJanus kinase inhibitors baricitinib and ritlecitinib are approved for the treatment of severe alopecia areata (AA). However, prospective real-world data on effectiveness, disease burden, and tolerability are limited.ObjectiveTo ev…